Inflammatory Response
Conditions
Brief summary
The aim of the present study is to determine the effect of Iso-alpha Acids and Xanthohumol from hops on the immune response in overweight participants.
Detailed description
The aim of the present study is to investigate whether the oral intake of Xanthohumol and Iso-alpha Acids has different protective effects on the immune response of isolated blood cells from overweight people with people with incipient metabolic diseases, what the time course of the effect is and whether the levels of the substances differ from normal-weight individuals. After taking a fasting blood sample, the study participants receive one of the study drinks and a light breakfast. Both should be consumed within 15 minutes. Further blood samples are taken 1, 2, 3, 4 and 6 hours after the drinks have been consumed. To assess the effect of Xanthohumol and Iso-alpha Acids or a combination of both, clinical parameters, blood lipids, blood glucose, uric acid and inflammatory markers will be determined. Furthermore, blood cells, isolated from blood samples of each time point, will be stimulated for measuring inflammatory markers.
Interventions
DIETARY_SUPPLEMENTXanthohumol
Participants receive a study drink supplemented with Xanthohumol (0 mg = Placebo or 0.75 mg soluble Xanthohumol)
DIETARY_SUPPLEMENTIso-alpha Acids
Participants receive a study drink supplemented with Iso-alpha Acids (0 mg = Placebo or 45 mg Iso-alpha Acids)
DIETARY_SUPPLEMENTXanthohumol + Iso-alpha Acids
Participants receive a study drink supplemented with Xanthohumol and Iso-alpha Acids (0 mg = Placebo or 0.75 mg + 45 mg soluble Xanthohumol + Iso-alpha Acids)
Sponsors
University of Vienna
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* BMI 25 - 29,9 kg/m² as well as one or more of the following incipient metabolic diseases: * pre-diabetes (fasting blood glucose 100-125 mg/dL), * fatty liver (grade 1-3), * high-normal blood pressure to mild hypertension (grade 1, systolic 140-159 mmHg)
Exclusion criteria
* History of diseases that could falsify the study results * inflammatory bowel diseases * malignant diseases of the gastrointestinal tract * food allergies * malabsorption * kidney or liver disease (except simple fatty liver) * symptomatic heart failure * Taking medication to treat these diseases * Consumption of special diets (e.g. vegan, gluten-free) * Pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in parameters of immune response | 6 hours | Changes in concentration of interleukin 6 (ng/ml) in cell culture supernatant of stimulated cells |
Countries
Austria
Outcome results
None listed